NUSAP1 and glioblastoma: NUSAP1 overexpression has been reported in bladder, cervical, colon, liver, lung, prostate, kidney, and breast cancers, glioblastoma, and oral squamous cell carcinoma [48–52]; multiple studies have correlated its overexpression with poor prognosis [15, 49, 50, 53–57].